Kairos Venture Partners — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Foldaxfoldax.com in 𝕏Apr 2017SEC filingmedium confidence

Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.

Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US

Frank Maguire(Executive Officer, Director)

BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)

Board seatJames Demetriades· per SEC Form D · $9M raise · filed May 2017

Co-investorsAngel Physicians Fund Kairos Venture Investments, Llc MemorialCare Innovation Fund BioStar Capital BioStar Ventures SUMMATION HEALTH VENTURES

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.